Company page

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. (ticker: AVTX) is a public company based in the United States with a market capitalization of approximately $772.7 million. The company focuses on developing innovative therapies for rare diseases. Avalo is committed to advancing its pipeline to address unmet medical needs in the healthcare sector.